Abstract
Understanding the thermodynamic basis of ligand recognition by G-protein-coupled receptors (GPCRs) is crucial for rational drug design. Here, we directly characterized the binding thermodynamics of the histamine H1 receptor (H1R) interacting with the geometric isomers of doxepin using isothermal titration calorimetry combined with molecular dynamics (MD) simulations. The Z-isomer binding to H1R_WT exhibited a larger enthalpic gain but a greater entropic loss than the E-isomer, whereas these differences were diminished in the T1123.37V mutant. Cluster analysis of MD trajectories revealed that Z-doxepin adopts a more restricted conformation upon binding, consistent with its enthalpy-driven interaction and reduced conformational entropy. These findings indicate that H1R distinguishes between E- and Z-isomers not only by affinity but also through distinct thermodynamic fingerprints. This study provides mechanistic insight into the enthalpy–entropy trade-off in GPCR–ligand interactions, highlighting the importance of conformational restriction and flexibility in designing ligands with optimized thermodynamic and functional properties.
Keywords: Histamine H1 receptor, Isothermal titration calorimetry, Enthalpy−entropy compensation, Doxepin isomers, Molecular dynamics simulation


G protein–coupled receptors (GPCRs) constitute a large family of membrane proteins that recognize hormones, neurotransmitters, and drugs, thereby regulating a wide variety of signaling pathways, and more than 30% of currently marketed drugs target GPCRs. Among them, the histamine H1 receptor (H1R) is a subtype involved in allergic and inflammatory responses, vascular permeability, airway constriction, and regulation of wakefulness and cognitive functions in the central nervous system. H1R has long been a major pharmacological target of antihistamines. First-generation antihistamines exhibit low receptor selectivity and cause central side effects, such as sedation, whereas second-generation drugs have improved selectivity but sometimes limited therapeutic efficacy. These limitations highlight the clinical and scientific importance of exploring H1R ligands from new perspectives. Doxepin, a tricyclic antidepressant that also acts as a potent H1R antagonist, exists as two geometric (E/Z) isomers differing in the configuration around the central double bond (Figure a). We previously determined the crystal structure of the H1R–doxepin complex, providing a structural framework for understanding H1R–antihistamine recognition (Figure b). In a separate study, we analyzed the binding of doxepin to the purified H1R using a racemic mixture of its E- and Z-isomers and demonstrated that the Z-isomer exhibits approximately 5-fold higher affinity than the E-isomer. Furthermore, we identified Thr1123.37 as a key residue contributing to this isomer-dependent selectivity.
1.

Structure of the H 1 R–doxepin complex. (a) Chemical structures of the doxepin isomers. (b) Crystal structure of the H1R–doxepin complex (PDB ID: 3RZE). The backbone of H1R is shown in khaki. The E-doxepin and Z-doxepin molecules are represented as purple and spring-green sticks, respectively. H1R residues interacting with doxepin are depicted as gray sticks.
In recent rational drug design, thermodynamic and kinetic information regarding the interactions between target proteins and ligands has proven to be highly valuable beyond simply binding affinity. Rather than focusing solely on the binding affinity (K d) or the Gibbs free energy change (ΔG), elucidating the respective contributions of enthalpy (ΔH) and entropy (−TΔS) provides important guidance for improving the quality and selectivity of hit compounds. , In particular, enthalpy–entropy compensation has attracted attention as a key concept for explaining ligand selectivity and isomer specificity. However, the molecular origins of this compensation are diverse and remain the subject of ongoing debate, as they can arise from various factors such as changes in solvation, conformational flexibility, and intermolecular interactions. , One of the pioneering studies of thermodynamic analyses of GPCRs was conducted by Borea and colleagues in the 1990s. They performed radioligand binding assays at multiple temperatures and derived the ΔH and ΔS of ligand binding from van’t Hoff plots. Using this approach, they discussed the thermodynamic parameters of agonists and antagonists for the A1 and A2 adenosine receptors as well as the CB1 and CB2 cannabinoid receptors. − Similar van’t Hoff analyses have also been conducted for H1R, revealing the overall thermodynamic characteristics of ligand binding and the role of Lys179ECL2 and Lys1915.39. , However, the structural origins of these thermodynamic parameters, namely, how specific molecular interactions within the receptor–ligand complex give rise to the observed enthalpic and entropic contributions, remain largely unexplored.
Isothermal titration calorimetry (ITC) is a powerful technique for studying the thermodynamics of protein–ligand interactions, as it enables direct and quantitative analysis of binding events and allows simultaneous determination of K d, ΔH, and ΔS. However, its application to membrane proteins remains a significant challenge due to experimental limitations such as sample instability and the difficulty of achieving sufficiently high yields of proteins. Consequently, reports of direct ITC measurements of GPCR–ligand interactions are extremely limited, and to our knowledge they are restricted to studies of CCR5 chemokine receptor with its agonist RANTES, and the β2-adrenergic receptor with a negative allosteric modulator. Nevertheless, these studies did not provide detailed discussions of the thermodynamic parameters involved.
In our previous study, we evaluated the binding affinities of the E- and Z-isomers of doxepin to purified H1R by analyzing the ratio of receptor-bound isomers using HPLC. The results indicated that the Z-isomer exhibited approximately 5-fold higher affinity for H1R than the E-isomer. In contrast, the T1123.37V mutant showed comparable affinities for both isomers, suggesting that Thr1123.37 is involved in the isomer selectivity of doxepin binding. Although the oxygen atom of doxepin is located within a distance suitable for hydrogen bonding with the hydroxyl group of Thr1123.37, our MD simulations revealed that such geometries are rarely observed, implying that hydrogen bonding is unlikely to be the major factor responsible for the observed selectivity. Because the structural and energetic basis underlying the higher affinity of the Z-isomer remains unclear, we then performed a detailed thermodynamic analysis of the H1R–doxepin interaction using ITC to characterize the energetic and molecular determinants of the isomer-dependent binding.
In this study, the construct referred to as H1R_WT corresponds to the one used in our previous crystallographic analysis, in which the N-terminal 19 residues were deleted and T4 lysozyme was fused into the third intracellular loop. The T1123·37V mutant was generated by introducing a point mutation into this construct. We expressed these proteins in large quantities using the Saccharomyces cerevisiae expression system and purified them by TALON resin affinity chromatography followed by size-exclusion chromatography as the final purification step (Supplementary Figure 1). We first performed thermodynamic analyses using ITC to characterize the interactions between doxepin (E/Z mixture) and H1R_WT or the T1123.37V mutant, respectively (Supplementary Figure 2). The obtained thermodynamic parameters (ΔG, ΔH, and – TΔS) are summarized in Table . Although no substantial difference in binding affinity was observed between the wild-type and mutant receptors, their enthalpic and entropic contributions differed. The interaction between H1R_WT and doxepin was characterized as enthalpy–entropy driven, with a dominant enthalpic contribution and a relatively small entropic component. (Figure a). This enthalpic contribution likely arises mainly from van der Waals and other nonpolar interactions rather than hydrogen bonding, as our previous study demonstrated that Thr1123.37 and the oxygen atom of doxepin do not form a hydrogen bond. In contrast, the T1123.37V mutant exhibited a smaller binding enthalpy but a greater entropic contribution (Figure b). These results suggest that Thr1123.37 contributes to enthalpic stabilization in doxepin recognition by H1R.
1. Thermodynamic Parameters of H1R_WT and T1123.37V Binding to Doxepin (E/Z Mixture and Individual Isomers) Determined by ITC .
| N | K d [nM] | ΔH [kcal/mol] | –TΔS [kcal/mol] | ΔG [kcal/mol] | |
|---|---|---|---|---|---|
| WT–Mix | 0.57 ± 0.06 | 8.0 ± 3.0 | –8.4 ± 0.5 | –2.7 ± 0.6 | –11.1 ± 0.2 |
| WT–E | 0.56 ± 0.02 | 10.0 ± 1.3 | –7.9 ± 0.2 | –3.0 ± 0.1 | –10.9 ± 0.1 |
| WT–Z | 0.58 ± 0.01 | 4.5 ± 1.4 | –11.1 ± 0.3 | –0.3 ± 0.2 | –11.4 ± 0.2 |
| T1123.37V–Mix | 0.72 ± 0.08 | 9.8 ± 2.2 | –4.6 ± 0.4 | –6.3 ± 0.6 | –10.9 ± 0.1 |
| T1123.37V–E | 0.72 ± 0.05 | 6.2 ± 2.7 | –4.2 ± 0.2 | –7.0 ± 0.5 | –11.2 ± 0.3 |
| T1123.37V–Z | 0.75 ± 0.04 | 15.5 ± 12.4 | –4.2 ± 0.1 | –6.7 ± 0.7 | –10.9 ± 0.7 |
Mix denotes doxepin (E/Z mixture), and N represents the stoichiometry. The data are expressed as the mean ± standard deviation (SD) from three independent measurements. However, for the H1R_T1123.37V–doxepin (E/Z mixture) interaction, the values represent the mean ± SD from two independent measurements. As described in the Experimental Procedures, the concentrations of each isomer were corrected and the ITC data were reanalyzed accordingly.
2.
Thermodynamic profiles of the interactions between H 1 R and doxepin (E/Z mixture). (a) Interaction between H1R_WT and doxepin (E/Z mixture). (b) Interaction between H1R_T1123.37V and doxepin (E/Z mixture). The graphs were generated based on the thermodynamic parameters summarized in Table .
Next, we obtained the individual E- and Z-isomers of doxepin and performed thermodynamic analyses of their interactions with H1R_WT and the T1123.37V mutant. The corresponding thermograms and reanalyzed binding curves are shown in Supplementary Figure 3. Initially, the concentrations of each isomer solution were determined by matching the absorbance at 280 nm to that of doxepin (E/Z mixture). However, the stoichiometries (N values) obtained from the ITC measurements differed between the E- and Z-isomers, even though the same protein preparation was used, suggesting that the ligand concentrations were inaccurate. Therefore, the concentrations were corrected based on the absorbance at 254 nm, which is used for the quantitative analysis of doxepin in the U.S. Pharmacopeia (USP), and the ITC data were reanalyzed (details are provided in Experimental Procedures). The resulting thermodynamic parameters (ΔG, ΔH, and – TΔS) are summarized in Figure and Table . The interactions between H1R_WT and doxepin isomers were overall enthalpy-driven (Figure a). When the two isomers were compared, Z-doxepin showed a 3.2 kcal/mol larger binding enthalpy gain but a 2.6 kcal/mol greater entropic penalty than E-doxepin. In contrast, for the H1R_T1123.37V mutant, both isomers exhibited similar values of binding enthalpy and entropy (Figure b). In our previous study, we reported that the Z-isomer displayed approximately 5.2-fold higher affinity for wild-type H1R compared with the E-isomer, whereas no difference in affinity was observed for the T1123.37V mutant. Consistent with those findings, the ITC analysis in this study also showed that the Z-isomer tended to bind with higher affinity to the wild-type receptor, while the two isomers exhibited comparable affinities for the mutant receptor. Taken together, these findings indicate that the hydroxyl group of Thr1123.37 contributes to the balance between enthalpic gain and entropic loss during ligand binding, with a more pronounced effect in the interaction with the Z-isomer, thereby shaping the observed isomer selectivity.
3.
Thermodynamic profiles of the interactions between H 1 R and doxepin isomers. (a) Interactions of H1R_WT with E-doxepin and Z-doxepin. (b) Interactions of H1R_T1123.37V with E-doxepin and Z-doxepin. The graphs were generated based on the thermodynamic parameters summarized in Table .
ITC measurements revealed distinct thermodynamic profiles for the interactions between H1R and doxepin isomers. In particular, the binding of the Z-isomer to the H1R_WT was characterized by a larger entropic penalty compared with that of the E-isomer, whereas the thermodynamic differences between the isomers were largely diminished in the T1123.37V mutant. Our previous studies using MD simulations of the H1R-doxepin complexes revealed no significant structural differences within or around the H1R orthosteric pocket between the two doxepin isomers, and no water molecules were observed near Thr1123.37 or Val1123.37 in the ligand-bound states. These findings indicate that the thermodynamic differences observed between the WT and T1123.37V mutant receptors in this study are unlikely to arise from variations in direct doxepin–residue interactions, hydration states, or receptor conformational changes but rather arise from differences in the reduction of doxepin’s conformational entropy upon binding.
To examine this possibility, we performed a cluster analysis of doxepin conformations before and after receptor binding using MD simulation data (Figure ). Prior to binding, both isomers displayed similar cluster distributions (Figure a). However, upon binding to H1R_WT, the Z-isomer exhibited a pronounced bias toward several specific clusters (Clusters 1–10), whereas the E-isomer retained a broader conformational distribution (Figure b). In contrast, when bound to the T1123.37V mutant, both isomers showed conformational distributions similar to those of the unbound state (Figure c). These results suggest that in the WT receptor the hydroxyl group of Thr1123.37 may allow the Z-isomer to fit more snugly into the binding pocket and stabilize a specific conformation, thereby gaining greater enthalpic benefit at the cost of conformational entropy. This interpretation is consistent with the ITC data, which revealed that the binding of the Z-isomer to H1R_WT was associated with a larger enthalpic gain but a greater entropic loss than the E-isomer. In contrast, in the T1123.37V mutant, both isomers appear to retain higher conformational flexibility upon binding, resulting in similar thermodynamic profiles dominated by a larger entropic contribution. Such an enthalpy–entropy compensation driven by ligand conformational entropy has also been demonstrated in the interaction between galectin-3 and its stereoisomeric ligands through a combination of ITC, X-ray crystallography, NMR, and MD simulations. Collectively, these observations highlight a mechanistic link between the thermodynamic signature obtained from ITC and the conformational behavior observed in MD simulations, suggesting that the enthalpy–entropy trade-off underlying the isomer selectivity of doxepin can be largely attributed to the conformational restriction of the Z-isomer upon binding.
4.

Fractional distribution of doxepin conformational clusters. (a) Free doxepin in solution, (b) doxepin bound to H1R_WT, and (c) doxepin bound to the T1123.37V mutant H1R. The k-means algorithm with k = 50 was used to cluster the conformations.
This study directly characterized the thermodynamic profiles of the histamine H1 receptor (H1R) interacting with the geometric isomers of doxepin using ITC. The Z-Isomer binding to H1R_WT exhibited a larger enthalpic gain but a greater entropic loss than the E-isomer, whereas these differences were diminished in the T1123.37V mutant. MD cluster analysis revealed that the Z-isomer adopts a more restricted conformation upon binding, which is consistent with the observed enthalpy–entropy trade-off. Together, these findings demonstrate that H1R discriminates between the E- and Z-isomers not only by affinity but also through distinct thermodynamic fingerprints. While the present analysis suggests that differences in ligand conformational restriction contribute to the observed enthalpy–entropy compensation, contributions from solvent reorganization and hydration effects cannot be completely excluded. However, both the crystal structure and our MD simulations showed no persistent water molecules at the ligand–receptor interface for either isomer, implying that solvent-related contributions are likely comparable between the E- and Z-isomers under the experimental conditions used in this study. Accordingly, the observed thermodynamic differences are most consistently interpreted as arising from differences in the ligand conformational entropy rather than major changes in receptor hydration. Future work employing a reconstituted membrane system such as nanodiscs could therefore provide a more physiologically relevant view of GPCR–ligand energetics. Extending this combined thermodynamic and computational approach to other GPCRs, including agonist–antagonist pairs and biased ligands, will deepen our understanding of how environmental context, receptor flexibility, and ligand chemistry collectively define enthalpy–entropy balance and functional selectivity. Ultimately, such insights will aid rational drug design by enabling the development of ligands optimized not only for affinity but also for thermodynamic and conformational efficiency.
Supplementary Material
Acknowledgments
This work was funded in part by JSPS KAKENHI (Grant Numbers JP25709080 and JP19K06514) to M.S. This research was partially supported by Research Support Project for Life Science and Drug Discovery (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED under Grant Number JP24ama121033. This work was supported by JST SPRING, Grant Number JPMJSP2151.
Glossary
Abbreviations
- GPCR
G protein-coupled receptor
- ITC
isothermal titration calorimetry
- MD
molecular dynamics
- WT
wild-type
- HPLC
high performance liquid chromatography
- TEV
tobacco etch virus
- T4L
T4 lysozyme
- GFP
green fluorescent protein
- DMSO
dimethyl sulfoxide
- DDM
n-dodecyl-β-d-maltoside
- CHS
cholesteryl hemisuccinate
- SDS-PAGE
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsmedchemlett.5c00696.
Experimental procedures, purification profiles of H1R by size-exclusion chromatography, ITC thermograms, and UV–visible absorption spectra of doxepin (PDF)
M.S. conceived and coordinated the project, performed the binding assay, analyzed the results, and wrote the manuscript. H.K. performed receptor preparation and HPLC analysis, ITC measurements and wrote the manuscript. S.N. and K.T. performed ITC analysis and wrote the manuscript. T.A. conducted molecular dynamics simulations and wrote the manuscript.
The authors declare no competing financial interest.
References
- Zhang M., Chen T., Lu X., Lan X., Chen Z., Lu S.. G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery. Signal Transduct Target Ther. 2024;9:88. doi: 10.1038/s41392-024-01803-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lorente J. S., Sokolov A. V., Ferguson G., Schioth H. B., Hauser A. S., Gloriam D. E.. GPCR drug discovery: new agents, targets and indications. Nat. Rev. Drug Discov. 2025;24:458–479. doi: 10.1038/s41573-025-01139-y. [DOI] [PubMed] [Google Scholar]
- Simons F. E.. Advances in H1-antihistamines. N Engl J. Med. 2004;351:2203–2217. doi: 10.1056/NEJMra033121. [DOI] [PubMed] [Google Scholar]
- Simon F. E., Simons K. J.. H1 antihistamines: current status and future directions. World Allergy Organ J. 2008;1:145–155. doi: 10.1186/1939-4551-1-9-145. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shimamura T., Shiroishi M., Weyand S., Tsujimoto H., Winter G., Katritch V., Abagyan R., Cherezov V., Liu W., Han G. W., Kobayashi T., Stevens R. C., Iwata S.. Structure of the human histamine H1 receptor complex with doxepin. Nature. 2011;475:65–70. doi: 10.1038/nature10236. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kaneko H., Korenaga R., Nakamura R., Kawai S., Ando T., Shiroishi M.. Binding characteristics of the doxepin E/Z-isomers to the histamine H(1) receptor revealed by receptor-bound ligand analysis and molecular dynamics study. J. Mol. Recognit. 2024;37:e3098. doi: 10.1002/jmr.3098. [DOI] [PubMed] [Google Scholar]
- Ferenczy G. G., Keseru G. M.. Thermodynamic profiling for fragment-based lead discovery and optimization. Expert Opin Drug Discov. 2020;15:117–129. doi: 10.1080/17460441.2020.1691166. [DOI] [PubMed] [Google Scholar]
- Geschwindner S., Ulander J., Johansson P.. Ligand Binding Thermodynamics in Drug Discovery: Still a Hot Tip? J. Med. Chem. 2015;58:6321–6335. doi: 10.1021/jm501511f. [DOI] [PubMed] [Google Scholar]
- Dragan A. I., Read C. M., Crane-Robinson C.. Enthalpy-entropy compensation: the role of solvation. Eur. Biophys J. 2017;46:301–308. doi: 10.1007/s00249-016-1182-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Peccati F., Jimenez-Oses G.. Enthalpy-Entropy Compensation in Biomolecular Recognition: A Computational Perspective. ACS Omega. 2021;6:11122–11130. doi: 10.1021/acsomega.1c00485. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Borea P. A., Dalpiaz A., Varani K., Guerra L., Gilli G.. Binding thermodynamics of adenosine A2a receptor ligands. Biochem. Pharmacol. 1995;49:461–469. doi: 10.1016/0006-2952(94)00464-W. [DOI] [PubMed] [Google Scholar]
- Dalpiaz A., Gessi S., Borea P. A., Gilli G.. Binding thermodynamics of serotonin to rat-brain 5-HT1A, 5HT2A and 5-HT3 receptors. Life Sci. 1995;57:A141–A146. doi: 10.1016/0024-3205(95)02072-Q. [DOI] [PubMed] [Google Scholar]
- Merighi S., Simioni C., Gessi S., Varani K., Borea P. A.. Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors. Biochem. Pharmacol. 2010;79:471–477. doi: 10.1016/j.bcp.2009.09.009. [DOI] [PubMed] [Google Scholar]
- Wittmann H. J., Seifert R., Strasser A.. Contribution of binding enthalpy and entropy to affinity of antagonist and agonist binding at human and guinea pig histamine H(1)-receptor. Mol. Pharmacol. 2009;76:25–37. doi: 10.1124/mol.109.055384. [DOI] [PubMed] [Google Scholar]
- Kobayashi C., Tanaka A., Yasuda T., Hishinuma S.. Roles of Lys191 and Lys179 in regulating thermodynamic binding forces of ligands to determine their binding affinity for human histamine H(1) receptors. Biochem. Pharmacol. 2020;180:114185. doi: 10.1016/j.bcp.2020.114185. [DOI] [PubMed] [Google Scholar]
- Rajarathnam K., Rosgen J.. Isothermal titration calorimetry of membrane proteins - progress and challenges. Biochim. Biophys. Acta. 2014;1838:69–77. doi: 10.1016/j.bbamem.2013.05.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nisius L., Rogowski M., Vangelista L., Grzesiek S.. Large-scale expression and purification of the major HIV-1 coreceptor CCR5 and characterization of its interaction with RANTES. Protein Expr Purif. 2008;61:155–162. doi: 10.1016/j.pep.2008.06.001. [DOI] [PubMed] [Google Scholar]
- Ahn S., Kahsai A. W., Pani B., Wang Q. T., Zhao S., Wall A. L., Strachan R. T., Staus D. P., Wingler L. M., Sun L. D., Sinnaeve J., Choi M., Cho T., Xu T. T., Hansen G. M., Burnett M. B., Lamerdin J. E., Bassoni D. L., Gavino B. J., Husemoen G., Olsen E. K., Franch T., Costanzi S., Chen X., Lefkowitz R. J.. Allosteric ″beta-blocker″ isolated from a DNA-encoded small molecule library. Proc. Natl. Acad. Sci. U. S. A. 2017;114:1708–1713. doi: 10.1073/pnas.1620645114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Monograph: Doxepin Hydrochloride. In USP-NF; USP: Rockville, MD, 2018. https://www.uspnf.com/sites/default/files/usp_pdf/EN/USPNF/errata467DoxepinHydrochloride.pdf. [Google Scholar]
- Verteramo M. L., Stenstrom O., Ignjatovic M. M., Caldararu O., Olsson M. A., Manzoni F., Leffler H., Oksanen E., Logan D. T., Nilsson U. J., Ryde U., Akke M.. Interplay between Conformational Entropy and Solvation Entropy in Protein-Ligand Binding. J. Am. Chem. Soc. 2019;141:2012–2026. doi: 10.1021/jacs.8b11099. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.


